GTCR CO-INVEST XI LP
SEC CIK 1591432 · EDGAR
BoughtSold
Most active insiders at SHC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WARBURG PINCUS & CO. | Dir, 10% | — | $579.51M |
| 2 | Warburg Pincus Partners II, L.P. | Dir, 10% | — | $510.75M |
| 3 | Warburg Pincus Partners GP LLC | Dir, 10% | — | $387.78M |
| 4 | GTCR FUND XI/A LP | Dir, 10% | — | $293.62M |
| 5 | Warburg Pincus Private Equity XI-C, L.P. | Dir, 10% | — | $281.70M |
| 6 | GTCR INVESTMENT XI LLC | Dir, 10% | — | $193.17M |
| 7 | WARBURG PINCUS LLC | Dir, 10% | — | $158.73M |
| 8 | GTCR CO-INVEST XI LP | Dir, 10% | — | $152.70M |
| 9 | Petras Michael B. Jr. | Executive COB, Dir | — | $33.51M |
| 10 | Rutz Michael P | Pres of Sterigenics | — | $2.83M |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-03-10 | 2026-03-06 | SHC | Sotera Health Co | GTCR CO-INVEST XI LP | Dir, 10% | S - Sale | $15.27 | -10.00M | 12.74M | -44% | -$152.70M |
| DI | 2023-01-24 | 2023-01-22 | MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | GTCR CO-INVEST XI LP | Dir, 10% | D - Sale to Iss | $0.00 | -4.58M | 119.09M | -4% | $0 |
| DI | 2022-01-04 | 2021-12-31 | MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | GTCR CO-INVEST XI LP | Dir, 10% | D - Sale to Iss | $0.00 | -2.57M | 123.67M | -2% | $0 |
| DI | 2021-09-13 | 2021-09-09 | MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | GTCR CO-INVEST XI LP | Dir, 10% | D - Sale to Iss | $50.00 | -2.93M | 21.68M | -12% | -$146.57M |
| DI | 2021-09-13 | 2021-09-09 | MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | GTCR CO-INVEST XI LP | Dir, 10% | J - Other | — | -17.07M | 126.24M | -12% | — |
Purchase Sale Sale after option exercise All abbreviations